Multiplexed selectivity screening of anti-GPCR antibodies
Science Advances · 05.05.2023 · 9 (18)
DOI: 10.1126/sciadv.adf9297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 05.05.2023. Verfasst von Leo Dahl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, 171 65 Solna, …. Hauptthemen laut MEDLINE: Signal Transduction, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
G protein–coupled receptors (GPCRs) control critical cellular signaling pathways. Therapeutic agents including anti-GPCR antibodies (Abs) are being developed to modulate GPCR function. However, validating the selectivity of anti-GPCR Abs is challenging because of sequence similarities among individual receptors within GPCR subfamilies. To address this challenge, we developed a multiplexed immunoassay to test >400 anti-GPCR Abs from the Human Protein Atlas targeting a customized library of 215 expressed and solubilized GPCRs representing all GPCR subfamilies. We found that ~61% of Abs tested were selective for their intended target, ~11% bound off-target, and ~28% did not bind to any GPCR. Antigens of on-target Abs were, on average, significantly longer, more disordered, and less likely to be buried in the interior of the GPCR protein than the other Abs. These results provide important insights into the immunogenicity of GPCR epitopes and form a basis for designing therapeutic Abs and for detecting pathological auto-Abs against GPCRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, 171 65 Solna, Sweden.
- Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, 1230 York Ave., New York, NY 10065, USA.
- Tri-Institutional PhD Program in Chemical Biology, New York, NY 10065, USA.
- Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, 171 65 Solna, Sweden.
- Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, 171 64 Solna, Sweden.
ORCID-Profile: Leo Dahl, Ilana B Kotliar, Annika Bendes, Tea Dodig-Crnković, Samuel Fromm, Arne Elofsson, Mathias Uhlén, Thomas P Sakmar, Jochen M Schwenk
Förderung
- NIGMS NIH HHS
Zitieren
APA
Dahl, L., Kotliar, I. B., Bendes, A., Dodig-Crnković, T., Fromm, S., Elofsson, A., Uhlén, M., Sakmar, T. P., & Schwenk, J. M. (2023). Multiplexed selectivity screening of anti-GPCR antibodies. Science Advances, 9(18). https://doi.org/10.1126/sciadv.adf9297
Vancouver
Dahl L, Kotliar IB, Bendes A, Dodig-Crnković T, Fromm S, Elofsson A, et al. Multiplexed selectivity screening of anti-GPCR antibodies. Science Advances. 2023;9(18). doi:10.1126/sciadv.adf9297
BibTeX
@article{Dahl2023,
author = {Dahl, Leo and Kotliar, Ilana B and Bendes, Annika and Dodig-Crnković, Tea and Fromm, Samuel and Elofsson, Arne and Uhlén, Mathias and Sakmar, Thomas P and Schwenk, Jochen M},
title = {Multiplexed selectivity screening of anti-GPCR antibodies},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {18},
doi = {10.1126/sciadv.adf9297}
}
EUVIMED